ARCHIVES

FDA Expands Nexavar Indication To Include Thyroid Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Should Be Cut First, DCT Board Says

December 4, 1981

BSA Approves Concept For Ovarian Cancer SPORE Grant

June 26, 1998

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

January 17, 1992

Caryn Lerman Recruited By Univ. Of Pennsylvania.

September 28, 2001

Newell Describes Progress To House, Senate Subcommittees

March 25, 1977

Scientists Glimpse Cellular Machines Inside Living Cells; Funding Opportunities

November 22, 2002